Hansard Global plc (HSD.L)
Douglas, IM
Hansard Global plc engages in the distribution and servicing of long-term investment products in the Isle of Man, the Bahamas, the Republic of Ireland, Malaysia, Japan, and the United Arab Emirates. Its key products include Ascend and Future Focus, which are regular and flexible premium products, as well as Global Select, a single premium product. The company also provides unit-linked regular or single premium life assurance and investment contracts; administration services; and marketing and development services. In addition, it offers Hansard OnLine, a platform that provides real-time access to policy information, transaction tools, and fund performance data for independent financial advisors (IFAs). The company distributes its products through IFAs and retail operations of financial institutions. It serves investors, institutions, and wealth-management groups. Hansard Global plc was founded in 1970 and is headquartered in Douglas, the Isle of Man.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.70% | -3.70% | +0.97% | +0.48% | +10.17% | +9.24% | +10.40% | +0.19% | -20.00% | -54.78% | +101.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-1.2% Q4'25: -8.1% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%-65.6% Q4'25: -34.5% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%-1.0% Q4'25: -0.5% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%-26.6% Q4'25: +4.1% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%— Q4'25: -35.1% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%+0.0% Q4'25: -0.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×-0.25× Q4'25: 0.07× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 250.15M (-100.0%)
|
—
est: 113.42M (-100.0%)
|
—
est: 60.42M (-100.0%)
|
—
est: 54.76M (-100.0%)
|
168.50M
est: 54.96M (+206.6%)
|
54.50M
est: 56.43M (-3.4%)
|
57.10M
est: 55.02M (+3.8%)
|
59.50M
est: 52.49M (+13.3%)
|
56.30M
est: 57.85M (-2.7%)
|
51.30M
est: 86.53M (-40.7%)
|
52.60M
est: 148.00M (-64.5%)
|
52.60M
est: 141.00M (-62.7%)
|
48.50M
est: 155.90M (-68.9%)
|
49.50M
est: 159.80M (-69.0%)
|
67.00M
est: 173.00M (-61.3%)
|
117.80M
est: 120.50M (-2.2%)
|
45.70M
est: 85.70M (-46.7%)
|
48.80M
est: 92.99M (-47.5%)
|
48.20M
est: 100.00M (-51.8%)
|
93.06M
93.06M – 93.06M
-6.9% YoY
|
102.37M
102.37M – 102.37M
+10.0% YoY
|
| EBITDA |
20.10M
est: -70.90M (+128.4%)
|
24.10M
est: 9.11M (+164.4%)
|
21.50M
est: 12.84M (+67.5%)
|
17.20M
est: 19.31M (-10.9%)
|
17.20M
est: 17.10M (+0.6%)
|
11.60M
est: 17.66M (-34.3%)
|
-40.90M
est: 11.31M (-461.7%)
|
23.80M
est: -14.58M (+263.2%)
|
12.60M
est: 9.99M (+26.1%)
|
-33.20M
est: -40.96M (+18.9%)
|
-124.60M
est: -30.32M (-311.0%)
|
4.90M
est: -21.86M (+122.4%)
|
-42.40M
est: -40.54M (-4.6%)
|
6.90M
est: -30.57M (+122.6%)
|
-139.50M
est: -49.03M (-184.5%)
|
5.70M
est: -34.15M (+116.7%)
|
-18.90M
est: -24.29M (+22.2%)
|
8.50M
est: -26.35M (+132.3%)
|
-10.90M
est: -28.34M (+61.5%)
|
-26.38M
-26.38M – -26.38M
+6.9% YoY
|
-29.01M
-29.01M – -29.01M
-10.0% YoY
|
| EBIT |
19.70M
est: -75.44M (+126.1%)
|
23.60M
est: 8.93M (+164.2%)
|
20.80M
est: 12.57M (+65.5%)
|
16.60M
est: 18.85M (-11.9%)
|
16.70M
est: 16.50M (+1.2%)
|
177.00M
est: 17.15M (+932.2%)
|
-41.50M
est: 10.82M (-483.5%)
|
23.20M
est: -15.52M (+249.5%)
|
12.00M
est: 9.32M (+28.8%)
|
-33.70M
est: 83.31M (-140.4%)
|
-125.00M
est: 51.90M (-340.8%)
|
4.50M
est: 36.68M (-87.7%)
|
-42.80M
est: 55.65M (-176.9%)
|
6.20M
est: 40.04M (-84.5%)
|
-140.40M
est: -52.17M (-169.1%)
|
4.90M
est: -36.34M (+113.5%)
|
-20.00M
est: -25.85M (+22.6%)
|
7.50M
est: -28.04M (+126.7%)
|
-12.80M
est: -30.16M (+57.6%)
|
-28.07M
-28.07M – -28.07M
+6.9% YoY
|
-30.87M
-30.87M – -30.87M
-10.0% YoY
|
| Net Income |
19.70M
est: 31.45M (-37.4%)
|
23.30M
est: 8.93M (+160.8%)
|
20.10M
est: 12.41M (+61.9%)
|
16.40M
est: 18.22M (-10.0%)
|
16.50M
est: 16.30M (+1.2%)
|
11.20M
est: 16.94M (-33.9%)
|
10.40M
est: 10.92M (-4.8%)
|
8.30M
est: 9.92M (-16.3%)
|
14.90M
est: 9.32M (+59.9%)
|
8.30M
est: 20.76M (-60.0%)
|
7.70M
est: 10.36M (-25.6%)
|
6.80M
est: 7.22M (-5.9%)
|
4.60M
est: 7.24M (-36.4%)
|
4.50M
est: 4.54M (-0.8%)
|
4.90M
est: 5.64M (-13.1%)
|
3.60M
est: 5.37M (-32.9%)
|
5.70M
est: 3.44M (+65.7%)
|
5.20M
est: 6.04M (-14.0%)
|
1.80M
est: 1.71M (+5.5%)
|
3.75M
3.75M – 3.75M
+120.1% YoY
|
3.03M
3.03M – 3.03M
-19.3% YoY
|
| SGA |
—
est: 66.63M (-100.0%)
|
—
est: 15.55M (-100.0%)
|
—
est: 20.03M (-100.0%)
|
—
est: 33.81M (-100.0%)
|
100.0K
est: 38.07M (-99.7%)
|
10.80M
est: 43.33M (-75.1%)
|
12.40M
est: 42.12M (-70.6%)
|
16.80M
est: 13.71M (+22.6%)
|
13.80M
est: 55.79M (-75.3%)
|
11.90M
est: 58.10M (-79.5%)
|
12.10M
est: 55.52M (-78.2%)
|
15.50M
est: 42.21M (-63.3%)
|
15.20M
est: 48.74M (-68.8%)
|
15.90M
est: 43.79M (-63.7%)
|
14.90M
est: 46.08M (-67.7%)
|
15.10M
est: 32.10M (-53.0%)
|
14.70M
est: 22.83M (-35.6%)
|
16.90M
est: 24.77M (-31.8%)
|
15.10M
est: 26.64M (-43.3%)
|
24.79M
24.79M – 24.79M
-6.9% YoY
|
27.27M
27.27M – 27.27M
+10.0% YoY
|
| EPS |
0.14
est: 0.23 (-38.7%)
|
0.17
est: 0.23 (-27.1%)
|
0.15
est: 0.16 (-7.7%)
|
0.12
est: 0.14 (-14.0%)
|
0.12
est: 0.12 (+3.6%)
|
0.08
est: 0.09 (-4.1%)
|
0.08
est: 0.07 (+8.5%)
|
0.06
est: 0.07 (-9.7%)
|
0.11
est: 0.10 (+8.0%)
|
0.06
est: 0.08 (-29.1%)
|
0.06
est: 0.06 (-6.1%)
|
0.05
est: 0.02 (+98.8%)
|
0.03
est: 0.04 (-20.0%)
|
0.03
est: 0.03 (-3.8%)
|
0.04
est: 0.04 (-13.2%)
|
0.03
est: 0.04 (-32.8%)
|
0.04
est: 0.03 (+66.4%)
|
0.04
est: 0.04 (-13.0%)
|
0.01
est: 0.01 (+4.8%)
|
0.03
0.03 – 0.03
+120.1% YoY
|
0.02
0.02 – 0.02
-19.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas Morfett | Chief Executive Officer & Executive Director | 435.8K | male |
| Oliver Anthony Byrne | Chief Financial Officer & Executive Director | 283.9K | male |
| Hazel Stewart | Company Secretary & Legal Manager | — | — |
| John Whitehouse | Chief Operating Officer | — | male |
| Alan Canny | Chief Actuary | — | — |
| Keith Brown | Head of Sales | — | — |
| Karen Corran | Head of People & Culture | — | female |
| Angela McCraith | Chief Risk Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HSD.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
